News

Spikes in IOP May Result From Particulate Matter in Avastin

by Dan Roberts In a presentation to Hawaiian Eye 2010, Malik Y. Kahook, MD, said that Avastin (bevacizumab) stored for long periods of time shows evidence of increased large particulate matter. This debris can block the eye’s trabecular network and lead to increased intraocular pressure (IOP) in patients being treated with the drug for wet [Read More]

Dominant Drusen

by Dan Roberts (Updated May 2010) Dominant Drusen is an inherited autosomal dominant condition that presents with small round white retinal spots (drusen) that eventually form into a honeycomb pattern in the area of the optic disc and macula. Vision loss is usually slow unless neovascularization (abnormal blood vessel growth and leakage) occurs. Dominant drusen [Read More]

Genetic testing sheds light on degenerative eye disease

Press Release February 13, 2007 Updated 5/16/2010 ANN ARBOR, Mich. — Genetic testing for eye disease is providing vital information about complex retinal diseases, especially when used to confirm a clinician’s diagnosis. In a newly published review of such tests that were conducted over a five-year period at the University of Michigan Kellogg Eye Center, [Read More]

Study Shows Lucentis and Avastin to be Equal

by Dan Roberts February 3, 2010 Investigators at Kaiser Permanente Southern California in Pasadena reported in the February 2010 issue of Ophthalmology that Avastin and Lucentis performed equally in recent testing. In an indirect comparison of the two drugs, study author Dr. Donald Fong and coauthors reviewed the records of 452 patients treated for wet [Read More]